KRAS and non-small cell lung carcinoma: As a result of the known importance of BMP signalling in the respiratory tract and the in vitro evidence of crosstalk between signalling pathways, we hypothesised that concurrent BMP inactivation and oncogenic k-ras mutation would be important in non-small-cell lung cancer (NSCLC).